Sales increase to €9.23 billion in fiscal year 2023 (2022: €9.07 billion)
Adjusted EBIT margin came in higher than the company’s own guidance at 3.7 percent (2022: 2.5 percent)
Free cash flow above the company’s expectations at €84.9 million (2022: €123.2 million)
Growth in electrification sales of around 21 percent to €1.3 billion (2022: €1.1 billion)
Order intake of more than €12 billion, of which around 70 percent in the electrification business
Order backlog as of December 31, 2023 stood at around €58 billion, with more than half electrification-related
First dividend distribution planned
Guidance for 2024: sales forecast between €8.3 billion and €8.8 billion, further improvement of adjusted EBIT margin between 4.5 percent and 5.0 percent, negative free cash flow of around €350 million expected
Check Also
NephroPlus’s flagship event ‘Aashayein’ spreads hope, celebrates courage, and brings joy to dialysis patients in Hyderabad
An empowering initiative in the city brought together over 250 dialysis patients and their families …